Metastases Spinal Tumor Market Research Report - Forecast till 2030

Metastases Spinal Tumor Market information: by type (extradural, and others), Diagnosis (laboratory tests, imaging tests, biopsy, and others), Treatment (non- operative treatment, surgical treatment, and others), End user- Forecast till 2030

ID: MRFR/Pharma/2752-HCR | December, 2022 | Region : Global

1. Report Prologue

2. Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

2.3 Market Structure

2.4. Market Segmentation

3. Research Methodology

3.1 Research Process

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

3.5 Forecast Model

4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Mega Trends

4.5 Macroeconomic Indicators

5. Market Factor analysis

5.1 Value Chain Analysis

5.2 Porters Five Forces Analysis

5.3 Demand & Supply: Gap Analysis

5.4 Pricing analysis

5.5 Investment Opportunity Analysis

5.6 Merger and Acquisition landscape

5.7 Upcoming Trends

6. Global Metastases spinal tumor Market by Type

6.1 Extradural

6.2 Metastatic Spinal Tumors of the Bone

6.3 Others

7. Global Metastases spinal tumor Market by Diagnosis

7.1 Metastatic Spinal Tumors of the Bone

7.2 Imaging tests

7.1.1 X-Ray

7.1.2 Computed Tomography (CT scan)

7.1.3 Magnetic Resonance Imaging (MRI scan)

7.1.4 Angiography

7.1.5 F-18 fluorodeoxyglucose positron emission tomography

7.1.6 Others

7.3 Biopsy

7.3.1 Percutaneous Needle Biopsy

7.3.2 Open Incisional and Excisional Biopsy

7.3.3 Others

7.4 Others

8. Global Metastases spinal tumor Market by Treatment

8.1 Non operative treatment

8.1.1 Medications

8.1.1.1 Anti-inflammatory drugs

8.1.1.2 Narcotics (opioids), Corticosteroids

8.1.1.3 RANKL inhibitors and bisphosphonates

8.1.1.4 Others

8.1.2 Radiation Therapy

8.1.3 Ablation

8.1.3.1 Radiofrequency ablation

8.1.3.2 Cryoablation

8.1.3.3 Others

8.1.4 Chemotherapy

8.1.5 Others

8.2 Surgical treatment

8.2.1 Minimally Invasive Surgery

8.2.1.1 Vertebral Fracture Treatments

8.2.1.1.1 Vertebroplasty

8.2.1.1.2 Kyphoplasty (Vertebral Augmentation)

8.2.1.1.3 Others

8.2.1.2 Transarterial Chemoembolization

8.2.1.3 Others

8.2.2 Open Surgery

8.2.2.1 Spinal Stabilization Surgery

8.2.2.2 Spinal Decompression Surgery

8.2.2.3 Others

8.2.3 Others

8.3 Others

9. Global Metastases spinal tumor Market by End User

9.1 Hospital and clinics

9.2 Ambulatory surgery centers

9.3 Academic institutes

9.4 Research centers

9.5 Others

10. Global Metastases spinal tumor Market by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 The US

10.2.1.2 Canada

10.2.2 Latin America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia

10.4.1 China

10.4.2 India

10.4.3 Japan

10.4.4 South Korea

10.4.5 Rest of Asia

10.5 Pacific

10.6 Middle East & Africa

10.6.1 UAE

10.6.2 Saudi Arabia

10.6.3 Egypt

10.6.4 Rest of the Middle East & Africa

11. Competitive Landscape

12. Company Profile

13. Conclusion

13.1 Key findings

13.1.1 From CEO’s viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Metastases Spinal Tumor Market

14. Appendix